Test4 Cancer
www.uneed2know.ukIntroducing Test4 Cancer, offering Genetic Screening tests for Prostate Cancer directly to your home. Our Genetic Screening test identifies men at high risk of developing prostate cancer, this is identified by detection of fault genes which are known to increase risk. Our test is a simple saliva test that can be carried out in the comfort of your own home or at one of our clinics. Prostate cancer is often left undetected due to having no signs and symptoms in the early stages. This means the disease can grow and progress to a stage where curative treatment is not possible. Approximately 10-15% of men with prostate cancer develop life threatening, aggressive tumors that sadly can spread to an incurable stage. Detecting the gene within your body early can prevent and reduce the disease severity and extend life prospects. A high proportion of males in the high-risk category carry faulty inherited repair genes and survival amongst this group is approximately only 50% of that of men with no genetic mutations. The presence of these faulty genes allows us to identify the risk of developing prostate cancer. Patients who are at risk of developing prostate cancer can benefit from increased surveillance and preventative steps to better manage the disease. The optional Clinical Pathway at Test4 can, not only provide information based on early detection through the test4 Genetic Screening Test , but also provide clinical support and options for further tests and referrals as needed. This support is provided by independent, qualified Consultant Urologists.
Read moreIntroducing Test4 Cancer, offering Genetic Screening tests for Prostate Cancer directly to your home. Our Genetic Screening test identifies men at high risk of developing prostate cancer, this is identified by detection of fault genes which are known to increase risk. Our test is a simple saliva test that can be carried out in the comfort of your own home or at one of our clinics. Prostate cancer is often left undetected due to having no signs and symptoms in the early stages. This means the disease can grow and progress to a stage where curative treatment is not possible. Approximately 10-15% of men with prostate cancer develop life threatening, aggressive tumors that sadly can spread to an incurable stage. Detecting the gene within your body early can prevent and reduce the disease severity and extend life prospects. A high proportion of males in the high-risk category carry faulty inherited repair genes and survival amongst this group is approximately only 50% of that of men with no genetic mutations. The presence of these faulty genes allows us to identify the risk of developing prostate cancer. Patients who are at risk of developing prostate cancer can benefit from increased surveillance and preventative steps to better manage the disease. The optional Clinical Pathway at Test4 can, not only provide information based on early detection through the test4 Genetic Screening Test , but also provide clinical support and options for further tests and referrals as needed. This support is provided by independent, qualified Consultant Urologists.
Read moreCountry
City (Headquarters)
Barnsley
Industry
Employees
11-50
Founded
2022
Social
Employees statistics
View all employeesPotential Decision Makers
Marketing and Systems Manager
Email ****** @****.comPhone (***) ****-****